Comment
Most studies ofblood gas concentrations have shown a linear decrease in oxygen tension with age.' This would suggest hypoxaemia in advanced age even in the absence of disease, but most of these studies included few patients over the age of 60.
The findings in our series of healthy inpatients are likely to represent the minimal estimate of the effect of age. Although the arterial oxygen tension declined significantly (p<0001) with age, this decline was not linear in advanced age. Elderly patients did better, probably following the "survival of the fittest" concept. Minor activity had a pronounced effect on oxygen tension, which was less evident on oxygen saturation because of the S shaped oxygen dissociation curve.
To define hypoxaemia one must rely on normal values related to age and activity. In the elderly determination of the oxygen saturation is helpful in differentiating a normal from a pathological state. 
Both these patients were positive for HIV antibody and had a clinical and radiological presentation suggestive of P carinni pneumonia that responded to treatment; thus the criteria fbr a diagnosis of AIDS were satisfied. ' In case 2 the diagnosis was complicated by the previous amiodarone treatment, though pneumonitis induced by amiodarone is unusual at a daily dosage less than 400 mg.23 Chest infections are common in the elderly. The increasing incidence of HIV infection and a reluctance of older homosexuals to admit to at risk behaviour may mean that elderly patients will die without AIDS being diagnosed. In the United States 10% of patients with AIDS are over 50, 2-5% over 60, and 0 4% over 70. The 
Methods and results
In Spain a system of spontaneous reporting of adverse drug reactions has been operating since 1983. Around 5000 reports have been received, of which 86 refer to cinnarizine as the suspected drug, 25 to flunarizine, and five to both drugs taken simultaneously. Of these 116 reports 87 described extrapyramidal symptoms or depression, or both: cinnarizine had been taken in 70 cases, flunarizine in 13, and both drugs in four.
Seventy patients developed tremor and parkinsonism while being treated with cinnarizine (see table) . They were not taking other drugs likely to induce parkinsonism, except for three patients, one of whom was also taking sulpiride, one thiethylperazine and dimenhydrinate, and one thioridazine (he subsequently recovered when cinnarizine was withdrawn without stopping thioridazine). Eight additional patients (two men, six women) presented with parkinsonism and three men presented with tremor while being treated with flunarizine (5 mg/day in one patient and 10 mg/day in 10). Four other patients developed parkinsonism (two men) or tremor (one man, one woman) while treated simultaneously with both drugs.
Four patients (two men, two women, aged 24 to 67) presented with depression while taking flunarizine (three patients, one of them also with tremor) or cinnarizine (one patient, who also presented with parkinsonism). The daily dose offlunarizine was 10 mg and of cinnarizine 150 mg. The intervals between starting drug treatment and the appearance of the first symptoms ranged from two days (in this patient tremor was also noted) to 10 months. The four patients improved when treatment stopped; three of them improved during the first month, but no exact information was available about the fourth. None of these patients were taking any other drug which could have contributed to their depression.
Comment
In Spain cinnarizine is marketed in 10 pharmaceutical preparations, eight of which are fixed dose combinations with other drugs. The most common indications are cerebral and peripheral arterial insufficiency. The top selling preparations contain 75 mg per tablet, and the recommended dose is 75 mg twice a day. Approved indications for flunarizine are the same as for cinnarizine. In the United Kingdom cinnarizine is marketed as 15 mg tablets for vestibular disorders and motion sickness, with a maximum recommended dose of 30 mg three times a day. 4 In Spain 5-7% of the population over the age of 60 may be receiving long term cinnarizine. 5 The consumption of flunarizine is also high: in 1986, 1-2 million units were dispensed. Not surprisingly therefore a large number of cases of extrapyramidal symptoms and depression attributed to these drugs have been assembled by our national scheme.
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